CMCSA vs GYRE · P/E 8.6, rev $61.40B vs rev $53.5M
Comcast Corp (CMCSA) versus Gyre Therapeutics Inc. (GYRE) — a side-by-side from cached financials, not a winner call.
Comcast Corp (CMCSA) is a telecom services company listed on US. It is led by Brian L. Roberts.
Gyre Therapeutics Inc. (GYRE) is a biotechnology company listed on NASDAQ.
Latest reported CMCSA revenue for 2026-06-30 was $61.40B. Net income was $5.70B. Revenue was up 95.2% from 2026-03-31 to 2026-06-30. CMCSA currently screens at market cap $130.64B and trailing P/E 8.6.
Latest reported GYRE revenue for 2026-06-30 was $53.5M. Net income was -$32.8M. GYRE currently screens at market cap $589.9M.
CMCSA currently screens at market cap $130.64B and trailing P/E 8.6. GYRE currently screens at market cap $589.9M.
Not investment advice. Open the CMCSA and GYRE stock pages for the full models.
Not investment advice.